Cargando…
Pharmacological signatures of the reduced incidence and the progression of cognitive decline in ageing populations suggest the protective role of beneficial polypharmacy
Preventive treatments for dementia are warranted. Here we show that utilization of certain combinations of prescription medications and supplements correlates with reduced rates of cognitive decline. More than 1,900 FDA-approved agents and supplements were collapsed into 53 mechanism-based groups an...
Autores principales: | Mayburd, Anatoly L., Koivogui, Mathilda, Baranova, Ancha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834256/ https://www.ncbi.nlm.nih.gov/pubmed/31693707 http://dx.doi.org/10.1371/journal.pone.0224315 |
Ejemplares similares
-
Increased lifespan, decreased mortality, and delayed cognitive decline in osteoarthritis
por: Mayburd, Anatoly L., et al.
Publicado: (2019) -
Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease
por: Mayburd, Anatoly, et al.
Publicado: (2013) -
Expression Variation: Its Relevance to Emergence of Chronic Disease and to Therapy
por: Mayburd, Anatoly L.
Publicado: (2009) -
MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
por: Marakasova, Ekaterina, et al.
Publicado: (2021) -
Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson's Disease: A Cross-Sectional Study
por: Ishii, Nobuyuki, et al.
Publicado: (2019)